PBH Prestige Consumer Healthcare Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PBH

Price (delayed)

$45.92

Market cap

$2.18B

P/E Ratio

12.83

Dividend/share

N/A

EPS

$3.58

Enterprise value

$4.15B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 65

Prestige Consumer Healthcare is a leading consumer healthcare products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands ...

Highlights
PBH's P/E is 16% below its 5-year quarterly average of 15.9 and 11% below its last 4 quarters average of 15.0
The equity has grown by 3.3% YoY
The company's debt has surged by 98% QoQ and by 98% YoY
The quick ratio has decreased by 36% YoY and by 15% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.prestigebrands.com
Peers: PFE PG NVS JNJ

Key stats

What are the main financial stats of PBH

PBH stock price

How has the Prestige Consumer Healthcare stock price performed over time
Intraday
-3.79%
1 week
-2.01%
1 month
-10.5%
1 year
-27.09%
YTD
-25.56%
QTD
-2.86%

Financial performance

How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$1.1B
Gross profit
$591.44M
Operating income
$290.17M
Net income
$172.01M
Gross margin
53.5%
Net margin
15.6%
The net income has contracted by 19% YoY and by 10% from the previous quarter
The company's net margin fell by 18% YoY and by 11% QoQ
The company's operating income fell by 14% YoY and by 6% QoQ
PBH's operating margin is down by 12% year-on-year and by 7% since the previous quarter

Price vs fundamentals

How does PBH's price correlate with its fundamentals

Growth

What is Prestige Consumer Healthcare's growth rate over time

Valuation

What is Prestige Consumer Healthcare stock price valuation
PBH P/E details
P/E
12.83
P/B
1.13
P/S
1.97
EV/EBIT
14.8
EV/EBITDA
12.94
EV/Sales
3.76
The EPS has contracted by 17% YoY and by 9% from the previous quarter
PBH's P/E is 16% below its 5-year quarterly average of 15.9 and 11% below its last 4 quarters average of 15.0
PBH's price to book (P/B) is 38% lower than its 5-year quarterly average of 1.9 and 21% lower than its last 4 quarters average of 1.5
The equity has grown by 3.3% YoY
The price to sales (P/S) is 27% lower than the 5-year quarterly average of 2.8 and 18% lower than the last 4 quarters average of 2.5

Efficiency

How efficient is Prestige Consumer Healthcare business performance
Prestige Consumer Healthcare's ROIC has decreased by 32% YoY and by 22% from the previous quarter
Prestige Consumer Healthcare's return on assets has decreased by 27% YoY and by 16% QoQ
PBH's ROE is down by 22% YoY and by 11% QoQ
The ROS has contracted by 14% YoY and by 8% from the previous quarter

Dividends

What is PBH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PBH.

Financial health

How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 72% higher than its total liabilities
PBH's total liabilities has surged by 68% year-on-year and by 65% since the previous quarter
The quick ratio has decreased by 36% YoY and by 15% from the previous quarter
The company's debt is 8% higher than its equity
The company's debt has surged by 98% QoQ and by 98% YoY
Prestige Consumer Healthcare's debt to equity has soared by 96% from the previous quarter and by 93% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.